{
    "organizations": [],
    "uuid": "d1da04b1980529c29e42f476fa5a8691e495261d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-medicenna-therapeutics-corp-report/brief-medicenna-therapeutics-corp-reports-qtrly-loss-per-share-0-09-idUSFWN1Q20SJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Medicenna Therapeutics Corp Reports Qtrly Loss Per Share $0.09",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 12, 2018 / 12:11 PM / in 10 minutes BRIEF-Medicenna Therapeutics Corp Reports Qtrly Loss Per Share $0.09 Reuters Staff \nFeb 12 (Reuters) - Medicenna Therapeutics Corp: * MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.09 \n* MEDICENNA THERAPEUTICS CORP - ENDED QUARTER WITH TOTAL AVAILABLE FUNDING OF APPROXIMATELY $14.5 MILLION, ENOUGH TO FUND OPERATIONS INTO Q1 2019 Source text for Eikon: Further company coverage:",
    "published": "2018-02-12T14:09:00.000+02:00",
    "crawled": "2018-02-12T14:24:26.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "therapeutic",
        "corp",
        "report",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "medicenna",
        "therapeutic",
        "corp",
        "medicenna",
        "therapeutic",
        "corp",
        "qtrly",
        "loss",
        "per",
        "share",
        "medicenna",
        "therapeutic",
        "corp",
        "ended",
        "quarter",
        "total",
        "available",
        "funding",
        "approximately",
        "million",
        "enough",
        "fund",
        "operation",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}